Format

Send to

Choose Destination
Eur J Nucl Med Mol Imaging. 2019 Apr 13. doi: 10.1007/s00259-019-04321-8. [Epub ahead of print]

Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.

Author information

1
Department of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur (UCA), 33 Avenue de Valombrose, 06100, Nice, France. ohumbert@unice.fr.
2
TIRO-UMR E 4320, UCA/CEA, Nice, France. ohumbert@unice.fr.
3
Clinical Research and Innovation Office, UCA, Nice, France. ohumbert@unice.fr.
4
Department of Neurology, Pasteur 2 University Hospital, UCA, Nice, France.
5
Department of Neuroradiology, Pasteur 2 University Hospital, UCA, Nice, France.
6
Department of Biostatistics, Centre Antoine-Lacassagne, UCA, Nice, France.
7
Department of Radiotherapy, Centre Antoine-Lacassagne, UCA, Nice, France.
8
Department of Neurosurgery, Pasteur 2 University Hospital, UCA, Nice, France.
9
Department of Medical Oncology, Pôle de Santé Saint Jean, Cagnes-sur-Mer, France.
10
Department of Medical Oncology, Centre Antoine-Lacassagne, UCA, Nice, France.
11
Department of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur (UCA), 33 Avenue de Valombrose, 06100, Nice, France.
12
TIRO-UMR E 4320, UCA/CEA, Nice, France.
13
Central Laboratory of Pathology, Pasteur I University Hospital, UCA, Nice, France.

Abstract

Jérôme Barriere was inadvertently missing in the original version of this article. He has participated to the study design, protocol writing and inclusion of a significant number of patients.

PMID:
30980100
DOI:
10.1007/s00259-019-04321-8

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center